EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+19.09%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$198M
AUM Growth
+$198M
(+32%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
18.21%
Top 10 Holdings %
Top 10 Hldgs %
56.63%
Holding
67
New
20
Increased
11
Reduced
18
Closed
11
Top Buys
| 1 |
QCP
Quality Care Properties, Inc.
QCP
|
$15.2M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$9.4M |
| 3 |
GSK
GSK
|
$8.95M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$8.72M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$6.28M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$14.4M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$4.01M |
| 3 |
eHealth
EHTH
|
$3.63M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$2.69M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$2.17M |
Sector Composition
| 1 | Healthcare | 68.17% |
| 2 | Real Estate | 10.84% |
| 3 | Industrials | 6.87% |
| 4 | Financials | 0.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
26
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.71M | 0.79% |
+85,090
| New | +$1.71M |
|
27
Ascendis Pharma
ASND
$12.1B
| $1.57M | 0.73% |
24,054
+11,936
| +98% | +$781K |
|
28
Puma Biotechnology
PBYI
$258M
| $1.56M | 0.72% |
22,924
-31,725
| -58% | -$2.16M |
|
29
CareTrust REIT
CTRE
$7.53B
| $1.47M | 0.68% |
108,264
-30,000
| -22% | -$408K |
|
30
Elevance Health
ELV
$72.4B
| $1.32M | 0.61% |
+6,000
| New | +$1.32M |
|
|
MDCO
31
DELISTED
Medicines Co
MDCO
| $1.3M | 0.6% |
+39,317
| New | +$1.3M |
|
32
Iovance Biotherapeutics
IOVA
$800M
| $1.1M | 0.51% |
+65,000
| New | +$1.1M |
|
33
Haemonetics
HAE
$2.57B
| $1.07M | 0.5% |
+14,646
| New | +$1.07M |
|
34
Centene
CNC
$14.8B
| $1.07M | 0.5% |
+10,000
| New | +$1.07M |
|
|
35
eHealth
EHTH
$126M
| $1.07M | 0.5% |
74,546
-254,009
| -77% | -$3.63M |
|
|
EPZM
36
DELISTED
Epizyme, Inc
EPZM
| $1.02M | 0.47% |
+57,449
| New | +$1.02M |
|
|
MGLN
37
DELISTED
Magellan Health Services, Inc.
MGLN
| $994K | 0.46% |
9,282
| – | – |
|
|
GBT
38
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $860K | 0.4% |
17,800
-21,000
| -54% | -$1.01M |
|
39
Align Technology
ALGN
$9.59B
| $753K | 0.35% |
3,000
-1,000
| -25% | -$251K |
|
|
AMRN
40
Amarin Corp
AMRN
$311M
| $753K | 0.35% |
+250,000
| New | +$753K |
|
41
iRadimed
IRMD
$898M
| $735K | 0.34% |
51,059
| – | – |
|
|
AFMD
42
DELISTED
Affimed
AFMD
| $716K | 0.33% |
+386,862
| New | +$716K |
|
43
BioCryst Pharmaceuticals
BCRX
$1.74B
| $711K | 0.33% |
148,959
-49,360
| -25% | -$235K |
|
44
Dynavax Technologies
DVAX
$1.19B
| $596K | 0.28% |
+30,000
| New | +$596K |
|
45
Arbutus Biopharma
ABUS
$753M
| $587K | 0.27% |
117,495
+10,000
| +9% | +$50K |
|
|
ALBO
46
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $587K | 0.27% |
+18,029
| New | +$587K |
|
|
MLNT
47
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $569K | 0.26% |
+76,837
| New | +$569K |
|
|
FOMX
48
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $551K | 0.26% |
+107,500
| New | +$551K |
|
49
Neurogene
NGNE
$284M
| $450K | 0.21% |
31,987
+11,987
| +60% | +$169K |
|
|
ISEE
50
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $409K | 0.19% |
149,100
| – | – |
|